Acepodia (ROCO:6976) ROCE % : -9.04% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Acepodia ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Acepodia's annualized ROCE % for the quarter that ended in Dec. 2024 was -9.04%.

Acepodia ROCE % Historical Data

The historical data trend for Acepodia's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia ROCE % Chart

Acepodia Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

-193.84

-43.50

-37.44

-15.57

-7.02

Acepodia Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial			-79.63	-23.12	-5.72	-4.76	-9.04

Acepodia ROCE % Calculation

Acepodia's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-466.5	/	( ( (6818.521 - 137.59)	+	(6819.324 - 206.067) )	/ 2 )
	=	-466.5	/	( (6680.931	+	6613.257)	/ 2 )
	=	-466.5	/	6647.094
	=	-7.02 %

Acepodia's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-609.984	/	( ( (6994.616 - 106.496)	+	(6819.324 - 206.067) )	/ 2 )
	=	-609.984	/	( ( 6888.12	+	6613.257 )	/ 2 )
	=	-609.984	/	6750.6885
	=	-9.04 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

Acepodia (ROCO:6976) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Acepodia ROCE % Related Terms

Thank you for viewing the detailed overview of Acepodia's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175

Website

https://www.acepodia.com

Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia Headlines

No Headlines